Breast Cancer
Guidelines
When to treat, delay, or omit breast cancer therapy in the face of COVID-19
Two groups have released recommendations for treating breast cancer patients during the pandemic.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Clinical Review
Evaluating and managing the patient with nipple discharge
For patients with pathologic nipple discharge, order the appropriate imaging studies, perform image-guided biopsy if necessary, and refer to a...
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
From the Journals
CLEOPATRA: Pertuzumab has long-term benefit in HER2+ breast cancer
Adding pertuzumab to trastuzumab and docetaxel as first-line therapy for metastatic HER2-positive breast cancer reduced the risk of death by 31%...
Guidelines
Guidelines on delaying cancer surgery during COVID-19
The American College of Surgeons has issued new guidelines for cancer surgery in the era of COVID-19.
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Conference Coverage
Study finds spironolactone doesn’t boost breast cancer recurrence
Little is known about its use in treating alopecia in breast cancer survivors on endocrine therapies.
From the Journals
CLL and breast cancer differ in the expression of regulatory microRNAs
A particular microRNA was found to be associated with prevascular invasion.